It has been 15 years since the first unequivocal proof that an immune checkpoint inhibitor (anti-CTLA-4, the T cell receptor shown in blue below; pink represents the antibody) was shown to extend survival in patients with metastatic melanoma and received FDA approval
Follow Ground Truths's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for Ground Truths.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
56:21